Evolution number of litigation cases and expenditure with monoclonal antibodies (MoAbs) (Bevacizumab, Cetuximab and Panitumumab) and tirosine kinase inhibitor (Regorafenib) for the treatment of cancer in Minas Gerais-Brazil : A preliminary analysis from 2009 to 2016

Autor: Silva, W., Cherchiglia, ML, Godman, Brian, Portela, MA, Izidoro, JB, Lana, AP, de Jesus, MA, Kambeba, AO, Dias, IC, Acurcio, FA, Andrade, EIG

Publikováno v: ISPOR 2019

Introduction: The last decade was marked by the widespread use of molecular biological agents in combination with 5-FU / oxaliplatin or irinotecan-containing regimens in the treatment of cancer. Such biological medicines have significantly increased

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::5f2a869cdff8af7dafaaceb107557567
https://strathprints.strath.ac.uk/67225/1/Silva_etal_ISPOR_2019_Evolution_number_of_litigation_cases_and_expenditure_with_monoclonal_antibodies.pdf

[Assessment of the coordination of primary healthcare: comparison of PMAQ-AB (Brazil) and international references].

Autor: Cruz MJB; Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brasil., Santos AFD; Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brasil., Macieira C; Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brasil., Abreu DMX; Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brasil., Machado ATGDM; Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brasil., Andrade EIG; Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brasil.

Publikováno v: Cadernos de saude publica [Cad Saude Publica] 2022 Feb 11; Vol. 38 (2), pp. e00088121. Date of Electronic Publication: 2022 Feb 11 (Print Publication: 2022).

The Budget Impact of Monoclonal Antibodies Used to Treat Metastatic Colorectal Cancer in Minas Gerais, Brazil.

Autor: da Silva WC; Postgraduate Program in Medicines and Pharmaceutical Services, School of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil. wania_logistica@hotmail.com., Godman B; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden.; Health Economics Centre, University of Liverpool Management School, Liverpool, UK.; Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa., de Assis Acúrcio F; Postgraduate Program in Medicines and Pharmaceutical Services, School of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil.; Postgraduate Program in Public Health, School of Medicine, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil., Cherchiglia ML; Postgraduate Program in Medicines and Pharmaceutical Services, School of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil.; Postgraduate Program in Public Health, School of Medicine, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil., Martin A; Health Economics Centre, University of Liverpool Management School, Liverpool, UK., Maruszczyk K; Health Economics Services, Warsaw, Poland., Izidoro JB; Divisão de Medicamentos Essenciais, Departamento de Assistência Farmacêutica, Secretaria de Estado de Saúde de Minas Gerais, Belo Horizonte, Brazil., Portella MA; Mario Penna Institute of Oncology-Minas Gerais, Belo Horizonte, Brazil., Lana AP; Postgraduate Program in Public Health, School of Medicine, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil., Campos Neto OH; Associate Professor of Undergraduate Pharmacy, Faculdade Ciências da Vida (FCV), Sete Lagoas, Brazil., Andrade EIG; Postgraduate Program in Medicines and Pharmaceutical Services, School of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil.; Postgraduate Program in Public Health, School of Medicine, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil.

Publikováno v: Applied health economics and health policy [Appl Health Econ Health Policy] 2021 Jul; Vol. 19 (4), pp. 557-577. Date of Electronic Publication: 2021 Jan 28.

Risk factors associated with antineoplastic chemotherapy-induced nausea and vomiting.

Autor: Simino GPR; Universidade Federal de Minas Gerais. Escola de Enfermagem. Departamento de Enfermagem Básica. Belo Horizonte, MG, Brasil., Reis IA; Universidade Federal de Minas Gerais. Instituto de Ciências Exatas. Departamento de Estatística. Belo Horizonte, MG, Brasil., Acurcio FA; Universidade Federal de Minas Gerais. Faculdade de Farmácia. Departamento de Farmácia Social. Belo Horizonte, MG, Brasil., Andrade EIG; Universidade Federal de Minas Gerais. Faculdade de Medicina. Departamento de Medicina Preventiva e Social. Belo Horizonte, MG, Brasil., Brazil NML; Instituto Mario Penna. Núcleo de Ensino e Pesquisa. Belo Horizonte, MG, Brasil., Cherchiglia ML; Universidade Federal de Minas Gerais. Faculdade de Medicina. Departamento de Medicina Preventiva e Social. Belo Horizonte, MG, Brasil.

Publikováno v: Revista de saude publica [Rev Saude Publica] 2020 Nov 09; Vol. 54, pp. 106. Date of Electronic Publication: 2020 Nov 09 (Print Publication: 2020).

[Budget impact of the incorporation of second-line drug treatment for diabetic macular edema in the Brazilian Unified National Health System from the perspective of the Minas Gerais State Health Department, Brazil].

Autor: Izidoro JB; Secretaria de Estado de Saúde de Minas Gerais, Belo Horizonte, Brasil.; Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Brasil., Piazza T; Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brasil., Andrade EIG; Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brasil., Alvares-Teodoro J; Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Brasil.

Publikováno v: Cadernos de saude publica [Cad Saude Publica] 2019 Aug 22; Vol. 35 (8), pp. e00145518. Date of Electronic Publication: 2019 Aug 22.